Editas Medicine, Inc. (EDIT) vs Eikon Therapeutics, Inc. Common Stock (EIKN)

A side-by-side comparison of Editas Medicine, Inc. and Eikon Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Editas Medicine, Inc. logo
EDIT
Editas Medicine, Inc.
$431M
$2.81HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$419M
$7.74HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT

Total return — EDIT vs EIKN

growth of $100 · dividends reinvested · last 1y
EDIT +35.4% (+35.4%/yr)EIKN -49.7% (-49.7%/yr)EDIT compounded faster over this window
50100150Start $100$135$50
EDIT EIKN

EDIT vs EIKN: by the numbers

  • •EDIT is the larger company ($431M vs $419M market cap).
  • •Both run net losses; EIKN's is the smaller (0.00% vs -157.32% net margin).

Metrics side by side

Valuation

MetricEDITEIKN
P/S ratio9.17N/A
P/B ratio4.100.90

Profitability

MetricEDITEIKN
Gross margin100.00%0.00%
Operating margin-245.15%0.00%
Net margin-157.32%0.00%
ROE-70.24%-69.06%
ROIC-48.61%-46.16%

Growth (annualized)

MetricEDITEIKN
Revenue CAGR (5Y)-10.34%N/A
Total return CAGR (5Y)-40.76%N/A

Go deeper

Full EDIT analysisFull EIKN analysisInteractive comparison tool

Dig into the metrics

Editas Medicine ROEEikon Therapeutics, Inc. Common Stock ROEEditas Medicine operating marginEikon Therapeutics, Inc. Common Stock operating marginEditas Medicine revenue growthEikon Therapeutics, Inc. Common Stock revenue growthEditas Medicine free cash flowEikon Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.